Pharmaceutical composition comprising kras g12d inhibitor
AssigneesJiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
InventorsRuilin Sha, Ziqing Duan, Haifeng Wang, Xinyong Tong, Pingping Wang, Biao Feng, Bin Wang
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a pharmaceutical composition comprising a KRAS G12D inhibitor. In particular, the present disclosure relates to a pharmaceutical composition, comprising a compound represented by formula I or a pharmaceutically acceptable salt thereof, and a lipid. The pharmaceutical composition can be better applied clinically.
Claims21
A pharmaceutical composition, comprising a compound of formula I or a pharmaceutically acceptable salt thereof and a lipid,
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.